Johnson & Johnson MedTech published an IDERHA position paper selected as August's Paper of the Month highlighting emerging policy developments and standardized RWE practices.
Public source
Publisher name
Public post
Honored that our IDERHA position paper was selected as August's Paper of the Month! Our paper highlights emerging policy developments and the importance of continued pro…
Company
Johnson & Johnson MedTech
- Industry
- Hospitals and Health Care
- Location
- New Brunswick, US
- Company size
- 10,001+ employees
About Johnson & Johnson MedTech
At Johnson & Johnson MedTech, we are working to solve the world’s most pressing healthcare challenges through innovations at the intersection of biology and technology. With deep expertise in surgery, orthopaedics, cardiovascular, and vision, we design healthcare solutions that are smarter, less invasive and more personalized. We are developing the next generation of med tech solutions to tackle the most pervasive and complex health challenges for people around the world. Community Guidelines: http://www.jnj.com/social-media-community-guidelines
See moreDiscover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Johnson & Johnson
Johnson & Johnson published a piece in the Financial Times exploring how policies focused primarily on short-term cost containment affect patient access, weaken incentives for innovation and investment, and undermine Europe's competitiveness.
Research & Knowledge
MDisrupt
MDisrupt published a new post breaking down five things worth locking in before a first coverage conversation, including evidence strategy, comparator selection, coding, budget impact, and medical society engagement.
Research & Knowledge
ISPOR—The Professional Society for Health Economics and Outcomes Research
ISPOR—The Professional Society for Health Economics and Outcomes Research published the September issue of Value in Health, featuring peer-reviewed research in health economics and outcomes research.
Research & Knowledge
Meditrial
Meditrial published a blog post introducing a clearer framework for highly innovative medical devices addressing serious clinical needs at the MDCG 2025-9 conference.
Research & Knowledge
Xcelrate UDI